Tarsus Pharmaceuticals, Inc. — Investor Relations & Filings
Tarsus Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates for diseases with limited treatment options. The company's initial focus is on eye care. Its lead product, XDEMVY® (lotilaner ophthalmic solution) 0.25%, is the first and only FDA-approved treatment for Demodex blepharitis. Tarsus is also advancing a pipeline of potential treatments for other conditions with high unmet needs, including ocular rosacea, Lyme disease prevention, and other indications across dermatology and infectious diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Tarsus Pharmaceuticals, Inc. (0001819790) (Filer) | 2026-05-06 | English | |
| 144 - Tarsus Pharmaceuticals, Inc. (0001819790) (Subject) | 2026-03-20 | English | |
| 4 - Tarsus Pharmaceuticals, Inc. (0001819790) (Issuer) | 2026-03-20 | English | |
| 4 - Tarsus Pharmaceuticals, Inc. (0001819790) (Issuer) | 2026-03-20 | English | |
| 4 - Tarsus Pharmaceuticals, Inc. (0001819790) (Issuer) | 2026-03-20 | English | |
| 4 - Tarsus Pharmaceuticals, Inc. (0001819790) (Issuer) | 2026-03-20 | English |
Browse filings by year
7 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Concord Drugs Limited
Develops, manufactures and markets pharmaceutical formulati…
|
538965 | IN | Manufacturing |
|
Công ty Cổ phần Dược Hậu Giang
Leading pharmaceutical enterprise specializing in R&D, manu…
|
DHG | VN | Manufacturing |
|
Công ty Cổ phần Dược phẩm Bến Tre
Pharmaceutical company established in 1963, producing and d…
|
DBT | VN | Manufacturing |
|
Công ty Cổ phần Dược phẩm Cửu Long
Producer of pharmaceuticals, medical equipment, and market-…
|
DCL | VN | Manufacturing |
|
Công ty Cổ phần Dược phẩm Imexpharm
48+ years in pharma manufacturing, EU-GMP certified, offeri…
|
IMP | VN | Manufacturing |
|
Công ty Cổ phần Dược phẩm OPC
Specializes in R&D and production of herbal medicines from …
|
OPC | VN | Manufacturing |
|
Công ty Cổ phần Dược phẩm Trung Ương Vidipha
Reputable manufacturer and distributor of diverse pharmaceu…
|
VDP | VN | Manufacturing |
|
Công ty Cổ phần Dược - Trang thiết bị Y tế Bình Định
Leading pharma and medical equipment company, pioneering in…
|
DBD | VN | Manufacturing |
|
Công ty Cổ phần S.P.M
Leading pharmaceutical manufacturer and distributor of dive…
|
SPM | VN | Manufacturing |
|
Công ty Cổ phần Tập đoàn F.I.T
A diversified economic group in pharmaceuticals, FMCG, real…
|
FIT | VN | Manufacturing |
Tarsus Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31511/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31511 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31511 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31511 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31511}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Tarsus Pharmaceuticals, Inc. (id: 31511)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.